CYTOSORBENTS CORPORATION Patent Applications Rejected
7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-02-17: Application 18022018; Invention Therapeutic And Cosmetic Wound Treatment; Applicant CYTOSORBENTS CORPORATION; Status Abandoned -- Failure to Respond to an Office Action.
- 2023-02-14: Application 17917322; Invention Blood And Toxin Filter Device And Use Of Same; Applicant CYTOSORBENTS CORPORATION; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-05-06: Application 17313424; Invention Hemocompatibility Modifiers For Cross-Linked Polymeric Material; Applicant CytoSorbents Corporation; Status Abandoned -- Failure to Respond to an Office Action.
- 2021-04-13: Application 17229265; Invention Method Of Treating Inflammation; Applicant CytoSorbents Corporation; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | 18022018 | Therapeutic And Cosmetic Wound Treatment | CYTOSORBENTS CORPORATION | Abandoned -- Failure to Respond to an Office Action | US20230310693A1 | Phillip P. CHAN Ophir ORTIZ Thomas D. Golobish Vincent J. CAPPONI Wei-Tai Young | United States United States United States United States United States | ALAWADI, SARAH |
| 2023-02-14 | 17917322 | Blood And Toxin Filter Device And Use Of Same | CYTOSORBENTS CORPORATION | Abandoned -- Failure to Respond to an Office Action | US20250222189A1 | Phillip P. CHAN Vincent J. Capponi | United States United States | WRUBLESKI, MATTHEW JAMES |
| 2021-05-06 | 17313424 | Hemocompatibility Modifiers For Cross-Linked Polymeric Material | CytoSorbents Corporation | Abandoned -- Failure to Respond to an Office Action | US20210402075A1 | Thomas D. Golobish Vincent J. Capponi David R. Clay | United States United States United States | ROGERS, JAMES WILLIAM |
| 2021-04-13 | 17229265 | Method Of Treating Inflammation | CytoSorbents Corporation | Abandoned -- Failure to Respond to an Office Action | US20210330697A1 | Phillip P. Chan Wei-Tai Young Vincent J. Capponi Thomas D. Golobish Humayra Begum Ali | United States United States United States United States United States | SILVERMAN, JANICE Y |
| 2020-02-13 | 16638834 | REDUCTION OF ADVANCED GLYCATION ENDPRODUCTS FROM BODILY FLUIDS | CYTOSORBENTS CORPORATION | Abandoned -- After Examiner's Answer or Board of Appeals Decision | US20200188427A1 | Andreas Viktor SIMM Jorg SCHEIER Christian STEINER Vincent CAPPONI Phillip P. CHAN | Germany United States United States United States United States | STEVENS, MARK V |
| 2018-09-05 | 16082376 | THE USE OF A HEMOCOMPATIBLE POROUS POLYMER BEAD SORBENT FOR REMOVAL OF PAMPS AND DAMPS | CYTOSORBENTS CORPORATION | Abandoned -- Failure to Respond to an Office Action | US20190060545A1 | Maryann GRUDA Pamela O'SULLIVAN Tamaz GULIASHVILI Andrew SCHEIRER Thomas GOLOBISH Vincent CAPPONI Phillip CHAN | United States United States United States United States United States United States United States | COUGHLIN, DANIEL F |
| 2014-12-23 | 14410901 | Methods for Reducing Contamination in a Biological Substance | Cytosorbents Corporation | Abandoned -- After Examiner's Answer or Board of Appeals Decision | US20150335576A1 | Phillip P. Chan Vincent J. Capponi Thomas D. Golobish Humayra Begum Ali | United States United States United States United States | GHALI, ISIS A D |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |